0001179110-17-001194.txt : 20170123
0001179110-17-001194.hdr.sgml : 20170123
20170123183302
ACCESSION NUMBER: 0001179110-17-001194
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170119
FILED AS OF DATE: 20170123
DATE AS OF CHANGE: 20170123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weiland Robert J.
CENTRAL INDEX KEY: 0001670648
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 17542209
MAIL ADDRESS:
STREET 1: C/O CYMABAY THERAPEUTICS, INC.
STREET 2: 7999 GATEWAY BLVD., SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
4
1
edgar.xml
FORM 4 -
X0306
4
2017-01-19
0
0001042074
CymaBay Therapeutics, Inc.
CBAY
0001670648
Weiland Robert J.
C/O CYMABAY THERAPEUTICS, INC.
7999 GATEWAY BLVD., SUITE 130
NEWARK
CA
94560
1
0
0
0
Stock Option (right to buy)
1.72
2017-01-19
4
A
0
12000
0
A
2027-01-18
Common Stock
12000
12000
D
The option vests in three annual installments from the vesting start date of January 19, 2017.
/s/ Sujal Shah, by power of attorney
2017-01-23